ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT

Abstract

Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also discussed.

Keywords

• atrial fibrillation
• thromboembolic complications
• anticoagulant therapy
• warfarin
• apixaban
• rivaroxaban
• dabigatran